| Product Name | MF | CAS | Details |
|---|
| Urotensin 2 antibody | Details |
| 4-Chloro-3-(1H)indazole carboxaldehyde | C8H5ClN2O | 102735-85-3 | Details |
| Oxoepistephamiersine | C21H25NO7 | 51804-68-3 | Details |
| 3-(4-Chlorophenyl)glutaric acid | C11H11ClO4 | 35271-74-0 | Details |
| 4-(Methanesulfonylmethyl)cyclohexan-1-amine hydrochloride | 1820607-77-9 | Details |
| 2-[1-(Propan-2-yl)piperidin-3-yl]acetic acid hydrochloride | C10H20ClNO2 | 1803611-99-5 | Details |
| Boc-Pro-Merrifield resin (200-400 mesh) | Details |
| 5-Hexyn-1-ol | C6H10O | 928-90-5 | Details |
| Methyl 5,6-diaminopyridine-2-carboxylate hydrochloride | C7H10ClN3O2 | 1803600-70-5 | Details |
| CLDN11 antibody | Details |
| ESD Blocking Peptide | Details |
| H-GDDDDK-2Naphthylamide | Details |
| Sun A, N-terminal, 30 amino acid polypeptide / Sun B, N-terminal, 30 amino acid polypeptide | Details |
| PGD antibody (biotin) | Details |
| 2-Hydrazinyl-N,N-dimethylbenzene-1-sulfonamide | C8H13N3O2S | 1154190-26-7 | Details |
| 6-Chloro-1,3-dioxaindan-5-ol | C7H5ClO3 | 105607-67-8 | Details |
| Bicyclo[2.2.1]hept-5-ene-2-sulfonamide | C7H11NO2S | 7167-08-0 | Details |
| 6-Methoxy-4-oxo-1,4-dihydro-quinoline-2-carboxylic acid methyl ester | C12H11NO4 | 82633-20-3 | Details |
| Potassium 2-(1H-1,2,3-benzotriazol-1-yl)acetate | 2138098-55-0 | Details |
| 2,5-Deoxyfructosazine | C12H20N2O7 | 17460-13-8 | Details |
| CHO LPLA2 ELISA Kit | Details |
| HS71L antibody | Details |
| 2-(5-Bromobenzo[b]thiophen-3-yl)ethanamine hydrochloride | C10H10BrNS.HCl | 22964-00-7 | Details |
| ((4-chloro-2-nitrophenyl)sulfonyl)(3-(phenylmethoxy)(2-pyridyl))amine | C18H14ClN3O5S | 1024479-59-1 | Details |
| H-VEGEGEEEGEEY-OH | Details |
| 2,3-Dihydro-1H-indene-1-carboxamide | C10H11NO | 33695-57-7 | Details |
| 4-(tert-Butylsulfanyl)aniline | C10H15NS | 16463-18-6 | Details |
| 1,3,5-Tri(1-phenyl-1H-benzo[d]imidazol-2-yl)phenyl | C45H30N6 | 192198-85-9 | Details |
| RDH13 antibody | Details |
| 2-Chloro-N-(2-{[4-(propan-2-yl)phenyl]methyl}-2,3-dihydro-1H-pyrazol-3-ylidene)acetamide | C15H18ClN3O | 1955564-27-8 | Details |
| Methyl stearidonate | C19H30O2 | 73097-00-4 | Details |
| 4-[(2,6-Difluorophenyl)methyl]-1,3-thiazol-2-amine | C10H8F2N2S | 1566067-94-4 | Details |
| 2-(acetylamino)-N-(4-methoxyphenyl)-3-phenylpropanamide | C18H20N2O3 | 6952-22-3 | Details |
| Tetrahydro-2H-thiopyran-4-sulfonyl chloride 1,1-dioxide | C5H9ClO4S2 | 1221722-37-7 | Details |
| 2-(Cyclopentylsulfanyl)-4-methylpyrimidine-5-carboxylic acid | C11H14N2O2S | 1552917-07-3 | Details |
| Goat anti Human IgG (Texas Red) | Details |
| Lipid IVa | C68H130N2O23P2 | 91841-27-9 | Details |
| Delavirdine mesylate | C23H32N6O6S2 | 147221-93-0 | Details |
| Carpinontriol B | C19H20O6 | 473451-73-9 | Details |
| (2S,4S)-Fmoc-4-trifluoromethylpyrrolidine-2-carboxylic acid | C21H18F3NO4 | 1242934-32-2 | Details |
| N-(4-Bromo-2-fluorophenyl)-2-chloropropanamide | C9H8BrClFNO | 923126-09-4 | Details |
| Hemin | C34H31ClFeN4O4- | 16009-13-5 | Details |
| Brexpiprazole impurity 3 | C25H27N3O3S | 1191900-58-9 | Details |
| HIF3 alpha antibody | Details |
| 10-Oxa-4-azatricyclo[5.2.1.0,2,6]dec-8-ene hydrochloride | C8H12ClNO | 1864058-33-2 | Details |
| (1-Benzyl-2-phenylpyrrolidin-2-yl)methanol | C18H21NO | 1864061-79-9 | Details |
| Canakinumab - in PBS buffer approx. 15mg/ml | 914613-48-2 | Details |
| H-RAYATEPHAK-OH | Details |
| Ethyl 2-(1H-pyrazol-1-yl)butanoate | C9H14N2O2 | 500335-69-3 | Details |
| Lactobionic acid ethyl ester | Details |
| Pantinin-3 | Details |
| (D-Arg1,D-Phe5,D-Trp7·9,Leu11)-Substance P | C79H109N19O12 | 96736-12-8 | Details |
| rac-Falcarinol | C17H24O | 4117-12-8 | Details |
| CD3e antibody (Spectral Red) | Details |
| N-Ethyl-3,5-dimethyl-N-(2-methylpropyl)-1H-pyrazole-4-sulfonamide hydrochloride | C11H22ClN3O2S | 1239484-85-5 | Details |
| {1-[(1,5-Dimethyl-1H-pyrazol-4-yl)methyl]piperidin-4-yl}methanamine | C12H22N4 | 1006483-89-1 | Details |
| 3-(4-Chlorophenyl)propanimidamide hydrochloride | 1102374-40-2 | Details |
| 5-Bromo-7-methoxy-2,3-dihydro-1H-inden-1-one | C10H9BrO2 | 881190-51-8 | Details |
| 2-[(tert-Butoxy)carbonyl]-6-oxa-2-azaspiro[3.4]octane-7-carboxylic acid | C12H19NO5 | 1251002-05-7 | Details |
| 6-Cyclopentylimidazo[2,1-b][1,3,4]thiadiazole | C9H11N3S | 1697870-38-4 | Details |
| CSTF1 antibody | Details |
| CYB5R3 protein (His tag) | Details |
| 3-OBenzyl-1, 2- O-isopropylidene-a- D- glucofuranose cyclic 5, 6- carbonate | Details |
| 2-(4-bromophenyl)-1-(4-oxachroman-6-yl)-6-phenyl-5,6,7-trihydroindol-4-one | C28H22BrNO3 | 1023798-69-7 | Details |
| N-(6-methanesulfonyl-1,3-benzothiazol-2-yl)-1-phenylcyclopentane-1-carboxamide | C20H20N2O3S2 | 1022237-89-3 | Details |
| 3-(2-(4-chloro-2-methylphenoxy)acetylhydrazidyl)-2-oxoindoline | C17H14ClN3O3 | 321966-67-0 | Details |
| 4-Amino-1-[3-(trifluoromethyl)phenyl]pyrrolidin-2-one hydrochloride | C11H12ClF3N2O | 1376380-85-6 | Details |
| 1-(2,2-Difluoroethyl)piperidin-4-amine dihydrochloride | C7H15ClF2N2 | 1201694-08-7 | Details |
| 2,4-dichloro-7-(trifluoromethyl)quinazoline | C9H3Cl2F3N2 | 396-02-1 | Details |
| Methyl 4-(2-Bromophenyl)-2,4-dioxobutanoate | C11H9BrO4 | 1035235-10-9 | Details |
| 2-[(tert-Butoxy)carbonyl]-2-azaspiro[3.5]nonane-1-carboxylic acid | C14H23NO4 | 247089-12-9 | Details |
| H-KLVALGINAV-OH | Details |
| GTS 21 Dihydrochloride | C19H22Cl2N2O2 | 156223-05-1 | Details |
| S-?(3-?Chlorophenyl)?-?S-?methyl-sulfoximine | C7H8ClNOS | 22133-00-2 | Details |
| 2-(4-Nitrophenyl)ethane-1-sulfonamide | C8H10N2O4S | 90007-78-6 | Details |
| 2-(3-Bromophenyl)pentan-3-one | C11H13BrO | 1518927-51-9 | Details |
| VTN antibody | Details |
| 4-Aminotetrahydro-2H-thiopyran-4-carbonitrile | C6H10N2S | 50289-20-8 | Details |
| Methyl 3-[(3-ethoxypropyl)amino]-2-methylpropanoate | C10H21NO3 | 1154921-20-6 | Details |
| 1-Amino-2-(4-chlorophenyl)butan-2-ol hydrochloride | C10H15Cl2NO | 1461714-02-2 | Details |
| [2-(Trifluoromethyl)thiophen-3-yl]methanamine hydrochloride | 2044902-26-1 | Details |
| 3-(3-chloro-4-methoxyphenyl)-2-((4-methylphenyl)sulfonyl)prop-2-enenitrile | C17H14ClNO3S | 861207-93-4 | Details |
| 5-Methoxy-2-methylpentanoic acid | C7H14O3 | 5470-68-8 | Details |
| 7,8-Dihydroneopterin | C9H13N5O4 | 1218-98-0 | Details |
| SETD2 Blocking Peptide | Details |
| 1-(Bromomethyl)-1-methoxycyclobutane | C6H11BrO | 30800-71-6 | Details |
| Leu-Asp-AMC | C20H25N3O6 | 929621-97-6 | Details |
| 4-[6-(Chloromethyl)-1,3-dioxaindan-4-yl]-1,5-dimethyl-1H-pyrazole hydrochloride | 2241140-30-5 | Details |
| 5-Methyl-10,13-dioxa-4,6-diazatricyclo[7.4.0.0,3,7]trideca-1(9),2,4,7-tetraene | C10H10N2O2 | 556020-32-7 | Details |
| 3-(1-Methyl-1H-1,2,3-triazol-4-yl)propanoic acid | C6H9N3O2 | 28819-28-5 | Details |
| 3-(Hydroxymethyl)-3-methyl-1λ?-thietane-1,1-dione | C5H10O3S | 2193064-98-9 | Details |
| Ethyl 2-[2-(2-hydroxyethyl)phenyl]acetate | C12H16O3 | 63969-86-8 | Details |
| 3-Ethyl-2-thioxo-4-imidazolidinone | C5H8N2OS | 32607-37-7 | Details |
| N-(2-Aminoethyl)-3-bromobenzamide hydrochloride | C9H12BrClN2O | 152535-09-6 | Details |
| Goat anti Rat IgG (Fab'2) (PE) | Details |
| 4-Methanesulfonyl-2-methylphenol | C8H10O3S | 20945-71-5 | Details |
| 3(R)-Iodomethyl-pyrrolidine-1-carboxylic acid tert-butyl ester | C10H18INO2 | 1187932-69-9 | Details |
| (cyclohexylamino)(4-(3-phenylprop-2-enyl)piperazinyl)methane-1-thione | C20H29N3S | 1164526-50-4 | Details |
| C.I.Basic blue 8 | C34H34ClN3 | 2185-87-7 | Details |
| (2S, 3S, 4R) -2- [(1R) - 1, 2-Dihydroxyethyl] -3, 4- pyrrolidinediol | C6H13NO4 | 120576-71-8 | Details |
| Product Total： Product Page： | ||||
| 925 926 927 928 929 930 931 932 933 934 935 936 937 938 939 940 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 958 959 960 961 962 963 964 965 966 967 968 969 970 971 972 973 974 975 976 977 978 979 980 981 982 983 984 985 986 987 988 989 990 991 992 993 994 995 996 997 998 999 1000 1001 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 | ||||